Concepedia

A. Cole Edwards

AC

Statistics

Publications

5

Citations

477

H-Index

5

Active since

2021

Affiliations

University of North Carolina at Chapel Hill(Current)

Harvard University

Dana-Farber Cancer Institute

Columbia University

Broad Institute

A. Cole Edwards is an author at University of North Carolina at Chapel Hill specializing in oncogenic signaling pathways, oncology, and molecular oncology.

ORCID

Publications per year

2021–2024

5

Publications

5

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text

, , +17

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

Jeffrey A. Klomp, Jeffrey A. Klomp, Jennifer E. Klomp et al. · Science · 2024 · 108 citations · Full text

, , +17

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer

Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp et al. · Science · 2024 · 81 citations · Full text

, , +17

TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors

A. Cole Edwards, Clint A. Stalnecker, Alexis Jean Morales et al. · Cancer Research · 2023 · 80 citations · Full text

, , +17

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

Andrew M. Waters, Tala O. Khatib, Bjoern Papke et al. · Cell Reports · 2021 · 33 citations · Full text

, , +17

1–5 of 5